FMC - Mercer County in Princeton, West Virginia - Dialysis Center

FMC - Mercer County is a medicare approved dialysis facility center in Princeton, West Virginia and it has 17 dialysis stations. It is located in Mercer county at 160 Springhaven Dr, Princeton, WV, 24740. You can reach out to the office of FMC - Mercer County at (304) 487-3866. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Mercer County has the following ownership type - Profit. It was first certified by medicare in April, 1998. The medicare id for this facility is 512516 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFMC - Mercer County
Location160 Springhaven Dr, Princeton, West Virginia
No. of Dialysis Stations 17
Medicare ID512516
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


160 Springhaven Dr, Princeton, West Virginia, 24740
(304) 487-3866

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMC - Mercer County from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1346352150
Organization NameFmc Dialysis Services Mercer County
Doing Business AsBio-medical Applications Of West Virginia, Inc.
Address160 Springhaven Dr Princeton, West Virginia, 24740
Phone Number(304) 487-3866

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data27
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL4

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center45
    Adult patient months included in Kt/V greater than or equal to 1.2416
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Research uncovers new mechanism involved in bone formation

    Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

    Teleflex announces completion of refinancing transactions

    Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

    Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

    Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

    Hepatitis C wonder drug Ribasphere gets approval from FDA

    The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Mercer County with elevated calcium levels.

Patients with hypercalcemia51
Hypercalcemia patient months451
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor56
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL26
Patients with Serumphosphor from 5.6 to 7 mg/dL25
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 45
Patient months included in arterial venous fistula and catheter summaries 362
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment57
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer36

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary49
Hospitalization Rate in facility190.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit325.9
Hospitalization Rate: Lower Confidence Limit116.2

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at FMC - Mercer County were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility26.8 (As Expected)
Readmission Rate: Upper Confidence Limit38.2
Readmission Rate: Lower Confidence Limit17.2

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC - Mercer County get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.98 (As Expected)
SIR: Upper Confidence Limit2.17
SIR: Lower Confidence Limit.36

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC - Mercer County's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 27
Transfusion Rate in facility40.2 (As Expected)
Transfusion Rate: Upper Confidence Limit195.3
Transfusion Rate: Lower Confidence Limit10.1

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at FMC - Mercer County lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary251
Mortality Rate in facility17.6 (As Expected)
Mortality Rate: Upper Confidence Limit23.1
Mortality Rate: Lower Confidence Limit13

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago


Dialysis Facility in Princeton, WV

FMC - Mercer County
Location: 160 Springhaven Dr, Princeton, West Virginia, 24740
Phone: (304) 487-3866

News Archive

Research uncovers new mechanism involved in bone formation

Osteoporosis is a disease that causes bones to fracture easily due to a reduction in both bone mass and quality. Aging is one of its leading causes, and it is estimated that around 200 million people are affected worldwide.

Teleflex announces completion of refinancing transactions

Teleflex Incorporated today announced that it has prepaid all of its outstanding senior notes issued in 2007, which had an aggregate outstanding principal amount of $196.6 million and would have matured in 2012 and 2014.

Research: Failure to control early, localized prostate cancer leads to poor clinical outcome

Failure to control early, localized prostate cancer results in a poor clinical outcome, according to research published in the International Journal of Radiation Oncology Biology Physics.

Hepatitis C wonder drug Ribasphere gets approval from FDA

The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.

Read more Medical News

› Verified 3 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.